Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodefici...

Por Sidhu, Jagdev, Rojavin, Mikhail, Pfister, Marc, Edelman, Jonathan
Publicado no Biol Ther (2014)

Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert(®) (C1-INH) Registry

Por Bygum, Anette, Martinez-Saguer, Inmaculada, Bas, Murat, Rosch, Jeffrey, Edelman, Jonathan, Rojavin, Mikhail, Williams-Herman, Debora
Publicado no Drugs Aging (2016)

Pharmacokinetics of Indinavir and Ritonavir Administered at 667 and 100 Milligrams, Respectively, Every 12 Hours Compared with Indinavir Administered at 800 Milligrams Every 8 Hour...

Por Rhame, Frank S., Rawlins, Sandy L., Petruschke, Richard A., Erb, Tara A., Winchell, Gregory A., Wilson, Helene M., Edelman, Jonathan M., Abramson, Murray A.
Publicado em 2004

The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension Trials

Por Ma, Shuren, Lin, Yong Y., Cantor, Jerome O., Chapman, Kenneth R., Sandhaus, Robert A., Fries, Michael, Edelman, Jonathan M., McElvaney, Gerard, Turino, Gerard M.
Publicado no Chronic Obstr Pulm Dis (2016)

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial

Por Merkies, Ingemar S. J., Lawo, John‐Philip, Edelman, Jonathan M., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Mielke, Orell, Tackenberg, Björn, Léger, Jean‐Marc
Publicado no J Peripher Nerv Syst (2017)

Quantitative disease progression model of α‐1 proteinase inhibitor therapy on computed tomography lung density in patients with α‐1 antitrypsin deficiency

Por Tortorici, Michael A., Rogers, James A., Vit, Oliver, Bexon, Martin, Sandhaus, Robert A., Burdon, Jonathan, Chorostowska‐Wynimko, Joanna, Thompson, Philip, Stocks, James, McElvaney, Noel G., Chapman, Kenneth R., Edelman, Jonathan M.
Publicado no Br J Clin Pharmacol (2017)

Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema

Por Craig, Timothy, Shapiro, Ralph, Vegh, Arthur, Baker, James W., Bernstein, Jonathan A., Busse, Paula, Magerl, Markus, Martinez-Saguer, Inmaculada, Riedl, Marc A., Lumry, William, Williams-Herman, Debora, Edelman, Jonathan, Feuersenger, Henrike, Machnig, Thomas, Rojavin, Mikhail
Publicado no Allergy Rhinol (Providence) (2017)

Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases

Por Wanner, Adam, Groft, Stephen C., Teagarden, J. Russell, Krischer, Jeffrey, Davis, Barry R., Coffey, Christopher S., Hickam, David H., Teckman, Jeffrey, Nelson, David R., McCaleb, Michael L., Loomba, Rohit, Strange, Charlie, Sandhaus, Robert A., Brantly, Mark, Edelman, Jonathan M., Farrugia, Albert
Publicado no Chronic Obstr Pulm Dis (2015)